# Kunming Pharmaceuticals Inc – FDA Inspection, Feb 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/kunming-pharmaceuticals-inc/5a9dead4-f2f6-48d6-aaba-ddcd77af9e14
Source feed: FDA_Inspections

> FDA inspection 1003819 of Kunming Pharmaceuticals Inc, February 23, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1003819
- Company Name: Kunming Pharmaceuticals Inc
- Inspection Date: 2017-02-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 552602 - 2008-11-26

## Related Officers

- [Company Rep](https://www.keypedia.com/people/lindsey-s-fleischman/19ba1e93-b804-487c-8c34-68dc703b0013)

Company: https://www.keypedia.com/companies/kunming-pharmaceuticals-inc/57084caf-f721-4351-8e20-164b16f93cd3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
